10 employees
Neuralstem, a biotherapeutics company, aims to apply stem cell research and technology to treat diseases of the central nervous system.
1996
$8M
from 1 investors over 1 rounds
NeuralStem raised $8M on March 25, 2013
Investors: Hercules Capital, Inc.